Aim. To evaluate the effectiveness of percutaneous coronary intervention (PCI) in patients with ischemic cardiomyopathy and identify opportunities for its improvement, as well as to conduct a comparative analysis with coronary artery bypass grafting (CABG). Materials and methods. A systematic search of medical literature published from 2017 to 2025 was conducted using PubMed, Scopus, Web of Science, and Google Scholar databases. 110 sources from high-impact factor journals were analyzed, including key randomized controlled trials (STICH, REVIVED-BCIS2), meta-analyses, and systematic reviews on ischemic cardiomyopathy and revascularization methods. Results. Ischemic cardiomyopathy is the leading global cause of heart failure, in the treatment of which revascularization plays an important role alongside quadruple pharmacotherapy. PCI demonstrates superior stroke risk reduction compared to CABG, while CABG excels in reducing repeat revascularization needs and improving long-term survival. In patients achieving complete revascularization, mortality risk decreased by 34% and repeat revascularization risk by 33%. Conclusion. When choosing between PCI and CABG in patients with ischemic cardiomyopathy, patient clinical characteristics, coronary anatomy, and comorbidities must be considered. The degree of revascularization and myocardial viability are important factors determining clinical outcomes.
| Mualliflar | Фозилов, Х, Абдукамилов, А, Fozilov , Xurshid, Abdukomilov , Abdulatif, Fozilov , Khurshid, Abdukomilov , Abdulatif |
|---|---|
| Jurnal | O‘zbekiston кardiologiyasi |
| Nashr sanasi | 2025-12-12 |
| Jild | 2 |
| Son | 4 |
| Betlar | 391-398 |
| Til | O‘zbek |
| DOI | 10.70626/cardiouz-2025-2-00070 |
DOI: 10.70626/cardiouz-2025-2-00070 · Maqolaning asl sahifasi
ischemic cardiomyopathy, percutaneous coronary intervention, coronary artery bypass grafting, heart failure, revascularization, myocardial viability, ишемическая кардиомиопатия, чрескожное коронарное вмешательство, аортокоронарное шунтирование, сердечная недостаточность, реваскуляризация, жизнеспособность миокарда, Ishemik kardiomiopatiya, teri orqali koronar aralashuv, aorto-koronar shuntlash, yurak yetishmovchiligi, revaskulyarizatsiya, miokard hayotiyligi
In the modern ESH (2023) and ESC (2024) guidelines on arterial hypertension (AH), the following key provisions for the use of combination therapies from the start of treatment have been clearly formulated for the first…
Aim. Systematic analysis and comparison of different reperfusion therapy methods in patients with ST-elevation acute coronary syndrome (STEMI), including primary percutaneous coronary intervention (pPCI) and…
Sudden cardiac death (SCD) in young athletes engaged in regular intensive training represents a rare but highly significant clinical and social problem. Although the incidence is low, SCD typically occurs unexpectedly…
Aim. To evaluate the effectiveness of ulinastatin as part of complex therapy in reducing the incidence of early postoperative complications in patients with multivessel coronary artery disease after CABG. Materials and…
Aim. To evaluate the influence of combined hypolipidemic therapy (statins in combination with ezetimibe and fenofibrate) and sodium-glucose cotransporter 2 inhibitors on epicardial fat thickness in patients with…
Obstructive hypertrophic cardiomyopathy (OHCMP) is a disease characterized by cardiac remodeling due to genetic factors. OHCMP can cause the development of dynamic obstruction in the outflow tract of the left ventricle…
Aim. To evaluate the immediate clinical and angiographic success in patients with NSTEMI, who underwent percutaneous coronary intervention (PCI) with the installation of a new generation of resorbable scaffolds…
This review synthesizes current evidence on early biomarkers of endothelial dysfunction (ED) in cardiovascular disease (CVD), emphasizing their role in diagnosis, prognosis, and management. ED, characterized by reduced…
Aim. To assess the prevalence of atherosclerotic lesions of the brachiocephalic arteries (BCA), their association with cardiovascular risk factors, and cardiovascular risk according to the SCORE scale in the population…
Aim. To evaluate the one-year dynamic effect of complete or incomplete revascularization on left ventricular ejection fraction (LVEF) in patients with a history of myocardial infarction (MI) who have preserved or mildly…